Data that were cross-referenced to monitor all-cause mortality between death records and laboratory diagnoses in the United Kingdom showed that liver disease is reduced once treatment for hepatitis C virus (HCV) infection is implemented, but researchers believe more research is needed to meet the World Health Organization’s global HCV elimination goal.
Compared with standard of care tests and most clinical signs, the molecular bacterial load assay demonstrated higher sensitivity and more rapid turnaround times for monitoring tuberculosis treatment.
Risks related to DTC testing include lack of understanding of the test by the consumer, incorrect test results, and erroneous interpretation of the results.
Positive results with respect to the presence of latent tuberculosis infection in patients with renal failure were more consistent with the use of QuantiFERON-TB Gold Plus testing compared with the use of QuantiFERON-TB Gold In-Tube testing.
The United States has reported the largest number of measles cases in the country in a single year since 1994 and since measles was eliminated in 2004.
Performing therapeutic bronchoscopy at the time of intensive care unit admission may decrease ventilator-associated pneumonia incidence in patients with level I trauma.
Researchers found data showing that long-term use of tenofovir disoproxil fumarate for hepatitis B virus was not effective, with a low HBeAg seroconversion rate, and that patients presented with a decrease in renal function and bone mineral density.
Telemedicine for infectious diseases (ID) occurring in patients who are hospitalized may be a promising way to provide ID expertise over a wide population.
Based on the 2016 International Working Group (IWG) diagnostic criteria for idiopathic pulmonary fibrosis (IPF), outcomes are relatively similar between patients with IPF with pneumonia and patients with an acute IPF exacerbation.
A 3-day course of either 300 mcg/kg/day or 600 mcg/kg/day of ivermectin may have similar mosquitocidal effects for up to 28-days postfeeding via membrane or direct skin feeding.
The American Psychiatric Association’s president, Altha Stewart, MD, sat with Valerie Jarrett, JD, for a fireside chat focused on the Affordable Care Act.
Researchers found data that were inconclusive for patients who are at risk of having their hepatitis B reactivated because of biologic treatment or chemotherapy and who were being evaluated with the Fujirebio Lumipulse G HBcrAg immunoassay.
